Higher rates of mortality seen among patients with systemic lupus erythematosus, with disparities by sex, race and ethnicity, and region.
Please provide your email address to receive an email when new articles are posted on . Despite declining mortality rates, racial, sex and geographic disparities persist for patients with lupus. Early ...
About Gazyva/Gazyvaro Gazyva®/Gazyvaro® (obinutuzumab) is a humanised monoclonal antibody designed with a Type II anti-CD20 region, for direct B cell death, and a glycoengineered Fc region, for higher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results